Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:ageRange |
18 years and older
|
| gptkbp:allocates |
non-randomized
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:clinicalTrials.govIdentifier |
gptkb:NCT01396499
|
| gptkbp:completedIn |
August 2013
|
| gptkbp:conditionStudied |
metastatic melanoma
|
| gptkbp:gender |
all
|
| gptkbp:intervention |
gptkb:PLX4032
gptkb:RO5185426 |
| gptkbp:location |
gptkb:Australia
gptkb:Canada gptkb:France gptkb:Germany gptkb:Italy gptkb:Spain gptkb:United_Kingdom gptkb:United_States |
| gptkbp:participants |
132
|
| gptkbp:purpose |
gptkb:psychotherapy
|
| gptkbp:sponsor |
gptkb:Hoffmann-La_Roche
|
| gptkbp:startDate |
July 2011
|
| gptkbp:status |
completed
|
| gptkbp:studyType |
interventional
|
| gptkbp:title |
gptkb:A_Study_of_RO5185426_(PLX4032)_in_Previously_Treated_Patients_With_Metastatic_Melanoma
|
| gptkbp:bfsParent |
gptkb:XL518
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
NCT01396499
|